publication date: Jun. 30, 2017
Ruben Mesa new director of UT Health San Antonio Cancer Center
Ruben Mesa was named director of the UT Health Cancer Center of the UT Health Science Center San Antonio.
He starts his job in August.
Mesa is professor of medicine and chair of the division of hematology & medical oncology at the Mayo Clinic in Arizona, and deputy director of the Mayo Clinic Cancer Center.
Mesa began his career in 1991 at the Mayo Clinic in Rochester before going to Arizona’s Mayo Clinic as chairman of the division of hematology and medical oncology.
He was named deputy director of the Mayo Clinic Cancer Center in 2012.
The organization developed Arizona’s largest stem cell transplant program, brought in state-of-the art proton-beam therapy and maintains the broadest and deepest clinical trial portfolio for cancer patients in the state.
During that time, the Arizona Mayo campus became a partner organization of the National Comprehensive Cancer Network and Association of American Cancer Institutes.
Mesa has been involved in myeloproliferative neoplasms research for more than 20 years. He serves as chair of the National Comprehensive Cancer Network’s panel that published the first U.S. guidelines on the diagnosis and treatment of myelofibrosis in the Journal of the National Cancer Center Network in 2016.
He was a major research leader contributing to the FDA’s approval of ruxolitinib for polycythemia vera and myelofibrosis. He is leading the investigation of several other drugs for these types of cancers.
He is co-principal investigator of the NCI program project grant-funded MPN Research Consortium, chairs the Standing Science and Education Committee for the International Society of Hematology and is involved in … Continue reading Ruben Mesa new director of UT Health San Antonio Cancer Center
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.